AC
AGN

Athos Capital’s Allergan plc AGN Stock Holding History

Athos Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-285,500
Closed -$50.6M – 29
2020
Q1 		$50.6M Buy
285,500
+214,403
+302% +$40.4M 35.06% 1
2019
Q4 		$13.6M Hold
71,097
– – 13.55% 2
2019
Q3 		$12M Buy
71,097
+40,248
+130% +$6.56M 11.74% 3
2019
Q2 		$5.17M Buy
+30,849
New +$4.27M 2.28% 8

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Athos Capital's AGN Position: Q2 2020 in Review

Athos Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 285,500 shares — an estimated $50.6M sold.

Athos Capital first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $50.6M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Athos Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Athos Capital sold 285,500 Allergan plc shares in Q2 2020, an estimated $50.6M.
  • Athos Capital first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Athos Capital's Allergan plc position peaked at $50.6M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Athos Capital's 13F filing for Q2 2020, filed 13 Aug 2020.